Cutaneous manifestations of COVID-19 in children: Four case presentations
Year 2022,
Volume: 6 Issue: 3, 395 - 398, 01.03.2022
Deniz Güven
,
Dilek Çoban
Abstract
The dermatological signs of Coronavirus disease 2019 (COVID19) in children are uncommon and different from adults. The majority of infected children were asymptomatic, and cutaneous symptoms of infection in children usually appear several weeks after the disease. This article describes four different cutaneous manifestations of COVID-19 in children, including chilblains, erythema multiforme-like lesions (EM), urticaria, and vesicular rash in terms of recalling to mind COVID-19 infection.
References
- 1. Hoang A, Chorath K, Moreira A, et al. COVID-19 in 7780 pediatric patients: A systematic review. E Clinical Medicine. 2020 Jun 26;24:100433. doi: 10.1016/j.eclinm.2020.100433. PMID: 32766542; PMCID: PMC7318942.
- 2. Parri N, Lenge M, Buonsenso D. Coronavirus Infection in Pediatric Emergency Departments (CONFIDENCE) Research Group. Children with Covid-19 in Pediatric Emergency Departments in Italy. N Engl J Med. 2020 Jul 9;383(2):187-90. doi: 10.1056/NEJMc2007617. Epub 2020 May 1. PMID: 32356945; PMCID: PMC7206930.
- 3. Khalili M, Iranmanesh B, Mohammadi S, Aflatoonian M. Cutaneous and histopathological features of coronavirus disease 2019 in pediatrics: A review article. Dermatol Ther. 2021 Jan;34(1):e14554. doi: 10.1111/dth.14554. Epub 2020 Dec 8. PMID: 33210417; PMCID: PMC7744858.
- 4. Andina D, Belloni-Fortina A, Bodemer C, et al. ESPD Group for the Skin Manifestations of COVID-19. Skin manifestations of COVID-19 in children: Part 1. Clin Exp Dermatol. 2020 Nov 12. doi: 10.1111/ced.14481. Epub ahead of print. PMID: 33180982.
- 5. Garcia-Lara G, Linares-González L, Ródenas-Herranz T, Ruiz-Villaverde R. Chilblain-like lesions in pediatrics dermatological outpatients during the COVID-19 outbreak. Dermatol Ther. 2020 Sep;33(5):e13516. doi: 10.1111/dth.13516. Epub 2020 Jun 23. PMID: 32378284; PMCID: PMC7261972.
- 6. Andina D, Belloni-Fortina A, Bodemer C, et al. ESPD Group for the Skin Manifestations of COVID-19. Skin manifestations of COVID-19 in children: Part 2. Clin Exp Dermatol. 2020 Nov 9. doi: 10.1111/ced.14482. Epub ahead of print. PMID: 33166429.
- 7. Labé P, Ly A, Sin C, et al. Erythema multiforme and Kawasaki disease associated with COVID-19 infection in children. J Eur Acad Dermatol Venereol. 2020 Oct;34(10):e539-e541. doi: 10.1111/jdv.16666. Epub 2020 Jul 6. PMID: 32455505; PMCID: PMC7283825.
- 8. Torrelo A, Andina D, Santonja C, et al. Erythema multiforme-like lesions in children and COVID-19. Pediatr Dermatol. 2020 May;37(3):442-446. doi: 10.1111/pde.14246. PMID: 32445583; PMCID: PMC7283638.
- 9. Algaadi SA. Urticaria and COVID-19: A review. Dermatol Ther. 2020 Nov;33(6):e14290. doi: 10.1111/dth.14290. Epub 2020 Sep 23. PMID: 32902087.
- 10. Dastoli S, Bennardo L, Patruno C, Nisticò SP. Are erythema multiforme and urticaria related to a better outcome of COVID-19? Dermatol Ther. 2020 Jul;33(4):e13681. doi: 10.1111/dth.13681. Epub 2020 Jun 9. PMID: 32447798; PMCID: PMC7283858.
- 11. Galván Casas C, Català A, Carretero Hernández G, et al. Classification of the cutaneous manifestations of COVID-19: a rapid prospective nationwide consensus study in Spain with 375 cases. Br J Dermatol. 2020 Jul;183(1):71-77. doi: 10.1111/bjd.19163. Epub 2020 Jun 10. PMID: 32348545; PMCID: PMC7267236.
- 12. Fernandez-Nieto D, Ortega-Quijano D, Jimenez-Cauhe J, et al. Clinical and histological characterization of vesicular COVID-19 rashes: a prospective study in a tertiary care hospital. Clin Exp Dermatol. 2020 Oct;45(7):872-875. doi: 10.1111/ced.14277. Epub 2020 Jun 22. PMID: 32384180; PMCID: PMC7273083.
- 13. Andina D, Belloni-Fortina A, Bodemer C, et al. ESPD Group for the Skin Manifestations of COVID-19. Skin manifestations of COVID-19 in children: Part 3. Clin Exp Dermatol. 2020 Nov 18:10.1111/ced.14483. doi: 10.1111/ced.14483. Epub ahead of print. PMID: 33207021; PMCID: PMC7753282.
Year 2022,
Volume: 6 Issue: 3, 395 - 398, 01.03.2022
Deniz Güven
,
Dilek Çoban
Supporting Institution
Yok
References
- 1. Hoang A, Chorath K, Moreira A, et al. COVID-19 in 7780 pediatric patients: A systematic review. E Clinical Medicine. 2020 Jun 26;24:100433. doi: 10.1016/j.eclinm.2020.100433. PMID: 32766542; PMCID: PMC7318942.
- 2. Parri N, Lenge M, Buonsenso D. Coronavirus Infection in Pediatric Emergency Departments (CONFIDENCE) Research Group. Children with Covid-19 in Pediatric Emergency Departments in Italy. N Engl J Med. 2020 Jul 9;383(2):187-90. doi: 10.1056/NEJMc2007617. Epub 2020 May 1. PMID: 32356945; PMCID: PMC7206930.
- 3. Khalili M, Iranmanesh B, Mohammadi S, Aflatoonian M. Cutaneous and histopathological features of coronavirus disease 2019 in pediatrics: A review article. Dermatol Ther. 2021 Jan;34(1):e14554. doi: 10.1111/dth.14554. Epub 2020 Dec 8. PMID: 33210417; PMCID: PMC7744858.
- 4. Andina D, Belloni-Fortina A, Bodemer C, et al. ESPD Group for the Skin Manifestations of COVID-19. Skin manifestations of COVID-19 in children: Part 1. Clin Exp Dermatol. 2020 Nov 12. doi: 10.1111/ced.14481. Epub ahead of print. PMID: 33180982.
- 5. Garcia-Lara G, Linares-González L, Ródenas-Herranz T, Ruiz-Villaverde R. Chilblain-like lesions in pediatrics dermatological outpatients during the COVID-19 outbreak. Dermatol Ther. 2020 Sep;33(5):e13516. doi: 10.1111/dth.13516. Epub 2020 Jun 23. PMID: 32378284; PMCID: PMC7261972.
- 6. Andina D, Belloni-Fortina A, Bodemer C, et al. ESPD Group for the Skin Manifestations of COVID-19. Skin manifestations of COVID-19 in children: Part 2. Clin Exp Dermatol. 2020 Nov 9. doi: 10.1111/ced.14482. Epub ahead of print. PMID: 33166429.
- 7. Labé P, Ly A, Sin C, et al. Erythema multiforme and Kawasaki disease associated with COVID-19 infection in children. J Eur Acad Dermatol Venereol. 2020 Oct;34(10):e539-e541. doi: 10.1111/jdv.16666. Epub 2020 Jul 6. PMID: 32455505; PMCID: PMC7283825.
- 8. Torrelo A, Andina D, Santonja C, et al. Erythema multiforme-like lesions in children and COVID-19. Pediatr Dermatol. 2020 May;37(3):442-446. doi: 10.1111/pde.14246. PMID: 32445583; PMCID: PMC7283638.
- 9. Algaadi SA. Urticaria and COVID-19: A review. Dermatol Ther. 2020 Nov;33(6):e14290. doi: 10.1111/dth.14290. Epub 2020 Sep 23. PMID: 32902087.
- 10. Dastoli S, Bennardo L, Patruno C, Nisticò SP. Are erythema multiforme and urticaria related to a better outcome of COVID-19? Dermatol Ther. 2020 Jul;33(4):e13681. doi: 10.1111/dth.13681. Epub 2020 Jun 9. PMID: 32447798; PMCID: PMC7283858.
- 11. Galván Casas C, Català A, Carretero Hernández G, et al. Classification of the cutaneous manifestations of COVID-19: a rapid prospective nationwide consensus study in Spain with 375 cases. Br J Dermatol. 2020 Jul;183(1):71-77. doi: 10.1111/bjd.19163. Epub 2020 Jun 10. PMID: 32348545; PMCID: PMC7267236.
- 12. Fernandez-Nieto D, Ortega-Quijano D, Jimenez-Cauhe J, et al. Clinical and histological characterization of vesicular COVID-19 rashes: a prospective study in a tertiary care hospital. Clin Exp Dermatol. 2020 Oct;45(7):872-875. doi: 10.1111/ced.14277. Epub 2020 Jun 22. PMID: 32384180; PMCID: PMC7273083.
- 13. Andina D, Belloni-Fortina A, Bodemer C, et al. ESPD Group for the Skin Manifestations of COVID-19. Skin manifestations of COVID-19 in children: Part 3. Clin Exp Dermatol. 2020 Nov 18:10.1111/ced.14483. doi: 10.1111/ced.14483. Epub ahead of print. PMID: 33207021; PMCID: PMC7753282.